机译:小细胞肺癌治疗的年轻患者的临床病理特征:免疫组织学和分子分析的重要性
Division of Thoracic Oncology National Cancer Center Hospital 5-1-1 Tsukiji Chuo-ku Tokyo 104;
Division of Thoracic Oncology National Cancer Center Hospital 5-1-1 Tsukiji Chuo-ku Tokyo 104;
Division of Pathology National Cancer Center Hospital Tokyo Japan;
Division of Thoracic Oncology National Cancer Center Hospital 5-1-1 Tsukiji Chuo-ku Tokyo 104;
Division of Thoracic Oncology National Cancer Center Hospital 5-1-1 Tsukiji Chuo-ku Tokyo 104;
Division of Thoracic Oncology National Cancer Center Hospital 5-1-1 Tsukiji Chuo-ku Tokyo 104;
Division of Thoracic Oncology National Cancer Center Hospital 5-1-1 Tsukiji Chuo-ku Tokyo 104;
Shien-Lab National Cancer Center Hospital Tokyo Japan;
Division of Breast and Medical Oncology National Cancer Center Hospital Tokyo Japan;
Division of Thoracic Oncology National Cancer Center Hospital 5-1-1 Tsukiji Chuo-ku Tokyo 104;
Chemotherapy; FISH; IHC; NUT midline carcinoma; NUT rearrangements;
机译:接受小细胞肺癌治疗的年轻患者的临床病理特征:免疫组织学和分子分析的意义
机译:下调MicroRNA 148b表达作为预测性生物标志物及其在非小细胞肺癌患者中的临床病理特征与预后意义
机译:临床病理学和分子特征的回顾性研究,术牙线烧蚀疗法治疗不可操作的早期非小细胞肺癌
机译:小细胞肺癌患者微流体平台富集的循环肿瘤细胞的分子表征
机译:小细胞肺癌的患者衍生异种移植模型为化学疗法交叉耐药机制提供分子见解
机译:老年和老年肺癌患者的临床病理和分子特征比较
机译:老年非小细胞肺癌切除患者的临床病理特征和EGFR基因突变状态